Potřebuje česká psychiatrie psychoterapii?

PhDr. Karel Koblic

Psychiatr. praxi. 2013;14(1):3  

Genetics of anxiety disorders

prof.MUDr.Ladislav Hosák, Ph.D., MUDr.Petr Šilhán, Mgr.Jiřina Hosáková

Psychiatr. praxi. 2013;14(1):7-9  

Heritability of anxiety disorders is the least of all psychiatric diseases – only 20 to 40 %. Environmental factors, especially the psychotraumatizing ones, are deciding. Although series of genetic association studies in anxiety disorders have already been performed, their results are typically negative, inconsistent, or non-replicated. On the present day, practically no gene can be considered as a causative one in the etiopathogenesis of anxiety disorders. A basically new knowledge can be attained by whole-genome association studies and genetic analyses of endophenotypes in the future. It will be useful in our finding of modern biological...

Stigmatisation in child and adolescent psychiatry

doc.MUDr.Libuše Stárková, CSc.

Psychiatr. praxi. 2013;14(1):10-13  

Mental illness is associated with stigma. The consequence of stigma is discrimination. Destigmatisation and improving the quality of care in psychiatry became the main targets for psychiatry within the last ten years. How is it with the stigmatisation of mentally ill children and adolescents? The aims of this article is to bring a review of basic informations about stigmatisation in child and adolescent psychiatry and to discuss the consequences and prevention of it.

Pharmacotherapy of borderline personality disorders in practice

MUDr.Bc.Aleš Grambal, MUDr.Zuzana Grambalová, prof.MUDr.Ján Praško, CSc.

Psychiatr. praxi. 2013;14(1):15-17  

Psychotherapeutic care in patients suffering from borderline personality disorder (BPD) is indicated in the first place. Pharmacotherapy is considered as adjuvant and often controversial way of treatment. The aim of the retrospective study is to report the pharmacological approach in Olomouc and to comapre it with guidlines for BPD treatment. Patients with borderline personality disorder treated in 2011 on department of psychiatry was included. Medication did not differ from the majority of best practices. But with a lack of strong evidence about its effect, it seems appropriate to move towards its reduction.

Complications of alcohol withdrawal syndrome - diagnostics and treatment

MUDr.Michal Dreisig, doc.MUDr.Tomáš Kašpárek Ph.D.

Psychiatr. praxi. 2013;14(1):18-20  

In the first part of this article the definition of pathophysiology of alcohol withdrawal syndrome is mentioned. The most important part of this review consists of the description of somatic complications, their causes, preventive strategies and therapy. Causal, supportive and complications- treated therapeutic measures are also described.

Incidence of depressive symptoms in the postpartum period

MUDr.Ľubomíra Izáková, PhD., MUDr.Marína Borovská, MUDr.Beata Baloghová, MUDr.Alexandra Krištúfková

Psychiatr. praxi. 2013;14(1):26-29  

Objective: Find an incidence of depressive symptoms among women in the postpartum period. Method: The analysis included 50 mothers, who completely fill out questionnaires at the last gynecologist visit before childbirth, at 4th–6th day after delivery and at the end of puerperium. Results: The average score at Zung Self-Rating Depression Scale did not reach values indicative of depressive disorder. The values indicative for depression occurred in the postpartum period and after puerperium consistently about plus 8 %. There were no differences when comparing the average values obtained on the Visual Analogue Mood Scale, although the presence...

Cipralex oral drops in treating agitation in elderly with dementia

MUDr.Vanda Franková, MUDr.Daniela Mojhová, MUDr.Jana Nyklesová, MUDr.Silvia Svaková

Psychiatr. praxi. 2013;14(1):30-33  

Agitation is a very frequent behavioral manifestation of dementia. Antipsychotic drugs are used in pharmacotherapy; they are, however, associated with a significant risk of adverse effects. Theoretical assumptions as well as clinical experience show a good effect of selective serotonin reuptake inhibitors in this indication. At the gerontopsychiatric ward of a mental hospital, we studied the efficacy and tolerability of escitalopram drops (Cipralex 20 mg/ml oral drops, solution) in 38 patients with dementia hospitalized for agitation as well as other behavioral disorders. We were surprised by a rapid onset of action (from day 3 of use), excellent...

Effective CBT and ineffective Petra - case study

Mgr.Roman Pešek

Psychiatr. praxi. 2013;14(1):34-36  

The article presents a case study of a depressive client treated by the cognitive behavioral approach in psychotherapy (CBT). Petra was not sufficiently supported by her father and her mother was emotionally unstable. There was a hypothesis: her family which was more cold-hearted and focused on effectivity created in Petra inner conviction: „I am not good enough“. It was activated during the period in which she was considerably ignored by her mother. Within the therapeutic process were applied especially methods of planned and progressive increase of activity, cognitive restructuring and therapeutic letters. Self-reflection of the...

SSRI treatment during pregnancy and breastfeeding

doc.MUDr.Tomáš Kašpárek, Ph.D.

Psychiatr. praxi. 2013;14(1):37-38  

Clinical practice brings the necessity of SSRI treatment even during pregnancy and breastfeeding. Current evidence suggest that the benefits of SSRI treatment of mental disorders overweight potential risks for pregnancy and breastfed child. However, individual approach, together with individual evaluation of benefit/risk ratio is required.

Act No. 372/2011 Coll., on Health Services, and its impact on outpatient psychiatry

MUDr.Jiří Švarc, Ph.D.

Psychiatr. praxi. 2013;14(1):40-44  

Act No. 372/2011 Coll., on Health Services and Conditions of Their Provision, effective as of 1 April 2012, replaces Act No. 20/1966 Coll., on Public Health Care. New information from this Act (not included in the previous Act) which is currently required in outpatient psychiatric practice is selected and presented in the paper. This includes new patient rights and responsibilities, but particularly the responsibilities of providers (e. g. to thoroughly inform patients of their health condition) as well as the rights of providers (e.g. to refuse a patient and to terminate care of a patient). Also discussed are the controversies concerning the...

Escitalopram: new clinical findings

prof.MUDr.Jiří Horáček, Ph.D.

Psychiatr. praxi. 2013;14(1):22-25  

This short overview is aimed at new clinical findings in escitalopram treatment. Studies published within a period of past two years were focused at pooled analyses comparing escitalopram with new antidepressants (agomelatine and SNRI), efficacy and safety in older and somatically ill patients (breast cancer, asthma bronchiale, acute coronary syndrome, vasomotor symptoms in menopause). The positive effect of escitalopram on gray matter volume has been documented in patients with panic disorder. Escitalopram treatment can be eased by the new form of orodispersible tablets. symptoms in menopause.

210 birth anniversary of doc. MUDr. Josef Bohumir Riedel

doc.MUDr.Josefa Bohumíra Riedela MUDr.Antonín Doněk, MUDr.Emanuel Doněk, MUDr.Jana Doňková

Psychiatr. praxi. 2013;14(1):45-46  

The authors introduced to biography of the first docent of psychiatry in Austria – Hungary monarchy doc. MUDr. Bohumir Joseph Riedel.